Related Experiment Video
Updated: Dec 30, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
Congcong Shen1, Hui Hua2, Lixiong Gu1
1Department of Dermatology, Affiliated Hospital of Nantong University, Nantong, 226001, P.R. China.
Abstract:
Melanoma is a highly malignant skin cancer with limited treatment options, the mechanism of the occurrence and development of melanoma is still unclear till now. Receptor for activated C kinase 1 (RACK1) is a scaffolding protein that mediates multiple signaling pathways; it interconnects distinct signaling pathways to control essential cellular processes. RACK1 was reported as an oncogene in human tumorigenesis, but little is known about its role in melanoma. This study aimed to investigate the expression of RACK1 in patients with melanoma and to reveal its possible functions in melanoma cells. The expression profiles of RACK1 detected in tumor tissues from melanoma patients showed that RACK1 was higher in tumor tissues, and its expression level was well associated with the clinical progression of melanoma (TNM stage, P=0.009). Furthermore, RNA interfering (RNAi) knockdown of RACK1 could efficiently suppress the proliferation, migration and invasion of A375 and A875 cells and promote their apoptosis. Taken together, these results suggest that RACK1 may be a poor prognostic factor in human melanoma, and it may be a new therapeutic target for melanoma treatment.
Insights
Receptor for activated C kinase 1 (RACK1) is elevated in melanoma and linked to disease progression. Reducing RACK1 inhibits melanoma cell growth and spread, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Melanoma is an aggressive skin cancer with poorly understood development mechanisms.
- Receptor for activated C kinase 1 (RACK1) is a scaffolding protein implicated in various signaling pathways and human tumorigenesis.
- The specific role of RACK1 in melanoma remains largely uncharacterized.
Purpose of the Study:
- To investigate RACK1 expression in melanoma patient tissues.
- To elucidate the functional role of RACK1 in melanoma cell behavior.
Main Methods:
- Analysis of RACK1 expression in melanoma tumor tissues.
- RNA interference (RNAi) to knockdown RACK1 in A375 and A875 melanoma cell lines.
- Assessment of cell proliferation, migration, invasion, and apoptosis.
Main Results:
- RACK1 expression is significantly higher in melanoma tumor tissues compared to normal tissues.
- RACK1 expression levels correlate with melanoma clinical progression (TNM stage).
- RACK1 knockdown suppressed melanoma cell proliferation, migration, and invasion, while promoting apoptosis.
Conclusions:
- RACK1 is upregulated in human melanoma and associated with advanced disease.
- RACK1 plays a crucial role in promoting melanoma cell growth and metastasis.
- RACK1 represents a potential prognostic marker and therapeutic target for melanoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
The Ras Gene
Ras is a...

